Searched for
PIRAMAL CRITICAL CARE
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Piramal Pharma deploying USD 85 mn capex this fiscal: Nandini PiramalPiramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD ...
- Piramal Pharma's Rs 1,050-cr rights issue gets Sebi's nodGoing by the draft papers, Piramal Pharma will issue fully paid-up equity shares of the company by way of a rights issue to its existing el...
- Piramal Pharma lists share on BSE, NSEIn October 2021, the board of directors of PEL approved the demerger of the pharmaceuticals business and simplification of the corporate st...
- Piramal Pharma to buy API maker Hemmo PharmaPiramal Pharma Solutions (PPS), the Contract Development and Manufacturing Organization (CDMO) of Piramal Pharma Limited, will acquire API ...
- Piramal Critical Care partners with Medivant Healthcare to supply injectable drugs in USPiramal Critical Care on Wednesday said it has partnered with US-based pharmaceutical outsourcing facility Medivant Healthcare to address s...
- COVID-19: Piramal Group commits Rs 25 cr donation to PM fundPiramal Foundation, the group's philanthropic arm that has presence in 25 states across India continues to work in partnership with the gov...
- Piramal Enterprises explores re-entry into Indian formulations businessThe company is looking at introducing respiratory and central nervous system formulations in India, the people said.
- Piramal acquires Mallinckrodt LLC's pain drug portfolio"Piramal Enterprises announced that its wholly-owned Critical Care subsidiary in the UK has completed its acquisition of a portfolio of dru...
- Piramal to acquire specialty products of UK's Mallinckrodt for $170 millionPiramal Enterprises Ltd (PEL) is the flagship company of Piramal Group and has a presence in the healthcare and financial services vertical...
- Piramal Enterprises to demerge healthcare, financial servicesPiramal Enterprises is growing largely organically with a CAGR of 17 per cent over last the five years.
- Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 croreThe transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...
- Open for acquisitions especially in OTC space: Nandini Piramal, Piramal EnterprisesThe deal allow us to leverage our distribution and our marketing network in over 50 countries, said Nandini Piramal.
- Piramal to buy select injectable brands from Janssen for up to $175 millionPiramal will pay an upfront cash of $155 million and the rest on meeting certain sales-related milestones, a press release said.
- Piramal Enterprises likely to hive off its critical care businessThe key driver is the valuation and if it does not match expectations, the deal may not move quickly,” an industry source, who claimed know...
- Piramal Critical Care Inc recalls veterinary product in USPiramal has product availability in more than 113 countries and is a part of the diversified Piramal Group that has operations in over 30 c...
- Piramal to get 3 bln rupees upfront payment from SRLDrugmaker Piramal Healthcare will receive 3 billion rupees as upfront payment from Super Religare Laboratories (SRL) for its diagnostics se...
- Piramal to share Abbott deal booty with employeesPiramal Healthcare, whose formulations business is being taken over by US drugmaker Abbott Inc in a $3.7-billion deal, will reward its over...
Load More
